Clinical trial

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

NCT05433753

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-05-24

PhaseN/A

Study timeline

Study start (actual)2022-05-24Date precision: day

Registry last updated2024-03-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2-positive Breast Cancerunresolved

Interventions

Sponsors & collaborators

National Cancer Center, Japanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05433753 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.